2024 SPEAKERS
Biopharma & Academia:
Andres Hurtado-Lorenzo
Senior Vice President - Translational Research & IBD Ventures
Crohn's & Colitis Foundation of America
Ann Fish-Steagall
Senior Vice Preisdent - Patient Services & Healthcare Delivery
LUNGevity Foundation
Duane Hassane
Senior Director - Head of Translational Omics, Hematology Research & Development
AstraZeneca
Eugean Jiwanmall
Senior Research Analyst for Medical Policy & Technology Assessment
Independence Blue Cross
Mark Gustavson
Senior Director & Global Head Computational Pathology Translational Science
AstraZeneca
Nishant Agrawal
Professor of Surgery, Co-Director, Head and Neck Surgical Oncology Chief of Otolaryngology–Head and Neck Surgery
University of Chicago
Rolando Yanes
Global Diagnostics Lead/Senior Principal Scientist, Clinical Biomarkers & Diagnostics
Amgen Inc.
Scott Pruitt
Scientific Associate Vice President - Clinical Research, Oncology Early Development
Merck & Co
Shelley Ann des Etages-Wong
Senior Director, Head of Non-Oncology Diagnostics and IM Translational Medicine
Pfizer
Tianjiao Wang
Associate Director, Biomarker and CDx Science & Operations
Adaptimmune Therapeutics plc.
Tricia Bal
Head - Oncology Precision Medicine, Global Commercial Strategy
Johnson & Johnson Services, Inc
Zheng Feng
Director - Global Clinical Biomarkers & Companion Diagnostics; Global Development
EMD Serono, An affiliate of Merck KGaA, Darmstadt, Germany
Diagnostic & Solution Providers:
Bernard Andruss
Vice President & General Manager - Molecular Diagnostic Division
Bio-Techne Corporation
Mark Roberts
Senior Director & Head of Precision Medicine Science, Strategy & Diagnostics Development
LabCorp
Scott Bornheimer
Associate Director - Biomarkers & CDx, Medical & Scientific Affairs
BD Technologies
Scott Pruitt
Scientific Associate Vice President - Clinical Research, Oncology Early Development
Merck & Co
